Sitka Biopharma
Sitka Biopharma, a spin-off company of CDRD Ventures Inc, has developed a novel polymer platform technology that improves drug absorption for cancer treatments. Its lead candidate is a formulation that allows taxane drugs to adhere and penetrate into the bladder wall, enhancing treatment benefit for bladder cancer. Preclinical proof-of-concept has been established and the company’s near term goal is to gain regulatory approval to commence clinical trials.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Sitka Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Sitka Biopharma
1 distinct titles indexed · top 1 shown.
- 1vice president, strategic partnerships
Sign up to unlock all 1 contacts at Sitka Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Sitka Biopharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.